Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base

Cancer

Volumn 115, Issue 6, 2009, Pages 1348-1355

  Combs, Stephanie E ^a,b   Nikoghosyan, Anna ^a,b   Jaekel, Oliver ^b   Karger, Christian P ^b   Haberer, Thomas ^a   Münter, Marc W ^a   Huber, Peter E ^a,b   Debus, Jürgen ^a   Schulz Ertner, Daniela ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Carbon ion radiotherapy; Childhood cancer; Chondrosarcomas; Chordomas; Skull base tumors

Indexed keywords

CORTICOTROPIN; GONADOTROPIN; GROWTH HORMONE;

ABDUCENS NERVE; ADULT; ALOPECIA; ARTICLE; CARBON ION RADIOTHERAPY; CHILDHOOD CANCER; CHONDROSARCOMA; CHORDOMA; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN DEFICIENCY; DIPLOPIA; ERYTHEMA; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; GONADOTROPIN DEFICIENCY; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; NERVE PARALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOMOTOR NERVE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; SKULL BASE TUMOR; SKULL IRRADIATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; CARBON; CHILD; CHILD, PRESCHOOL; CHONDROSARCOMA; CHORDOMA; FEMALE; HUMANS; IONS; MALE; RADIOTHERAPY, ADJUVANT; SKULL BASE NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 63449138449     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24153     Document Type: Article

References (35)

1. Debus J, Schulz-Ertner D, Schad L, et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys. 2000;47: 591-596.
2. Krayenbuhl H, Yasargil MG. Cranial chordomas. Prog Neurol Surg. 1975;6:380-434.
3. Castro JR, Linstadt DE, Bahary JP, et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys. 1994;29:647-655.
4. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175(suppl 2):57-63.
5. Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 1999;91:432-439.
6. Debus J, Hug EB, Liebsch NJ, et al. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys. 1997;39:967-975.
7. Noel G, Feuvret L, Calugaru V, et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol. 2005;44:700-708.
8. Noel G, Jauffret E, Crevoisier RD, et al. Radiation therapy for chordomas and chondrosarcomas of the base of the skull and cervical spine [in French]. Bull Cancer. 2002;89:713-723.
9. Schulz-Ertner D, Karger CP, Feuerhake A, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull- base chordomas. Int J Radiat Oncol Biol Phys. 2007;68:449-457.
10. Schulz-Ertner D, Nikoghosyan A, Hof H, et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys. 2007;67:171-177.
11. Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients. Strahlenther Onkol. 2003;179:598-605.
12. Haberer T, Becher W, Schardt D, Kraft G. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res A. 1993;330:296-305.
13. Scholz M, Kellerer AM, Kraft-Weyrather W, Kraft G. Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat Environ Biophys. 1997;36:59-66.
14. Kramer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radio- biology to treatment planning. Technol Cancer Res Treat. 2003;2:427-436.
15. Jakel O, Kramer M, Karger CP, Debus J. Treatment planning for heavy ion radiotherapy: clinical implementation and application. Phys Med Biol. 2001;46:1101-1116.
16. Kramer M, Jakel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol. 2000;45:3299-3317.
17. Jakel O, Kramer M, Schulz-Ertner D, et al. Treatment planning for carbon ion radiotherapy in Germany: review of clinical trials and treatment planning studies. Radiother Oncol. 2004;73(suppl 2):S86-S91.
18. Kramer M, Jakel O, Haberer T, et al. Treatment planning for scanned ion beams. Radiother Oncol. 2004;73(suppl 2):S80-S85.
19. Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part IV: further concepts and methods in survival analysis. Br J Cancer. 2003;89:781-786.
20. Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part I: basic concepts and first analyses. Br J Cancer. 2003;89:232-238.
21. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol. 2007;25:953-964.
22. Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer. 2005;104:338-344.
23. Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery. 1995;36:887-896.
24. Colli BO, Al-Mefty O. Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus. 2001;10:E1.
25. Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys. 1995;31:577-581.
26. Rutz HP, Weber DC, Goitein G, et al. Postoperative spot- scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at Paul Scherrer Institute. Int J Radiat Oncol Biol Phys. 2008;71:220-225.
27. Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE. Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys. 2002;52:1017-1024.
28. International Commission on Radiological Protection. Recommendations. Annals of the ICRP Publication 60. Oxford, UK: International Commission on Radiological Protection; 1990.
29. Guibout C, Adjadj E, Rubino C, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol. 2005;23:197-204.
30. Smilenov LB, Brenner DJ, Hall EJ. Modest increased sensitivity to radiation oncogenesis in ATM heterozygous versus wild-type mammalian cells. Cancer Res. 2001;61:5710-5713.
31. Smilenov LB, Lieberman HB, Mitchell SA, Baker RA, Hopkins KM, Hall EJ. Combined haploinsufficiency for ATM and RAD9 as a factor in cell transformation, apoptosis, and DNA lesion repair dynamics. Cancer Res. 2005;65:933-938.
32. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1-7.
33. Schneider U, Agosteo S, Pedroni E, Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys. 2002;53:244-251.
34. Yan X, Titt U, Koehler AM, et al. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nucl Instrum Methods Phys Res A. 2002;476:429-434.
35. Kase KR, Svensson GK, Wolbarst AB, Marks MA. Measurements of dose from secondary radiation outside a treatment field. Int J Radiat Oncol Biol Phys. 1983;9:1177-1183.